Search Results
Q&A: GARDP and Venatorx collaboration to develop new treatment for multidrug-resistant infections
Bringing new treatments for drug resistant infections to all who need them
Challenges of developing antibiotic combinations
An introduction to antibiotic research and development (R&D)
Manipulating the host response to treat infections
Target candidate profiles and target product profiles for new antimicrobials
The value of surveillance data in defining the medical need for new antimicrobials
Assay development for measuring antibiotic accumulation in Gram negative bacteria
NIAID Resources to Facilitate Discovery & Development of Anti Infectives
AMR R&D efforts in the CMC and formulation arena: Do it right the first time
Developing partnerships to bolster the antimicrobial resistance ecosystem: The role of GARDP
Representative Chrissy Houlahan visits VenatoRx
